Weight-Loss Drug War Heats Up: Oral Pills, Generics Reshape Market
The obesity drug market faces intense competition in 2026 as Novo Nordisk and Eli Lilly launch oral pills, generics enter, and prices drop globally. India and China prepare for major opportunities.